Absci (ABSI) EBITDA (2020 - 2026)
Absci's (ABSI) quarterly EBITDA came in at -$29.9 million in Q1 2026, down 13.54% year-on-year from -$34.6 million in Q1 2025, and down 1.41% quarter-over-quarter from -$29.5 million in Q4 2025.
Absci (ABSI) EBITDA (2020 - 2026) Analysis & Trends
Absci has disclosed EBITDA across 7 years of filings, most recently posting -$29.9 million for Q1 2026.
- EBITDA for Q1 2026 came in at -$29.9 million, down 13.54% year-over-year; the trailing twelve-month figure through Mar 2026 was -$118.2 million (down 10.09% YoY), and the FY2025 annual result was -$114.6 million, down 11.17% from the prior year.
- EBITDA came in at -$29.9 million for Q1 2026 at Absci, down from -$29.5 million in the prior quarter.
- In the past five years, EBITDA ranged from a high of -$19.6 million in Q4 2022 to a low of -$41.7 million in Q2 2023.
- The 5-year median for EBITDA is -$27.2 million (2022), against an average of -$27.2 million.
- Across the five-year window, EBITDA tumbled 169.15% in 2022 and surged 40.72% in 2024, its largest moves.
- Absci's EBITDA stood at -$19.6 million in 2022, then decreased by 19.91% to -$23.5 million in 2023, then declined by 24.3% to -$29.2 million in 2024, then declined by 0.8% to -$29.5 million in 2025, then fell by 1.41% to -$29.9 million in 2026.
- The last three EBITDA figures came in at -$29.9 million (Q1 2026), -$29.5 million (Q4 2025), and -$28.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.92 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -13.63 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -752,618.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | Absci | 1.13 Bn | 1.01 Bn | - | -29.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.89 Mn |
| Dec 31, 2025 | -29.47 Mn |
| Sep 30, 2025 | -28.52 Mn |
| Jun 30, 2025 | -30.28 Mn |
| Mar 31, 2025 | -26.32 Mn |
| Dec 31, 2024 | -29.24 Mn |
| Sep 30, 2024 | -27.03 Mn |
| Jun 30, 2024 | -24.73 Mn |
| Mar 31, 2024 | -22.07 Mn |
| Dec 31, 2023 | -23.52 Mn |
| Sep 30, 2023 | -21.91 Mn |
| Jun 30, 2023 | -41.72 Mn |
| Mar 31, 2023 | -23.33 Mn |
| Dec 31, 2022 | -19.62 Mn |
| Sep 30, 2022 | -27.17 Mn |
| Jun 30, 2022 | -28.72 Mn |
| Mar 31, 2022 | -29.50 Mn |
| Dec 31, 2021 | -25.16 Mn |
| Sep 30, 2021 | -23.64 Mn |
| Jun 30, 2021 | -41.21 Mn |